ArticleInvestigating Pirfenidone and Vitamin D for Targeting Cardiac and Renal Fibrotic Pathways in Experimentally-Induced Animal Model
ArticleInvestigating Pirfenidone and Vitamin D for Targeting Cardiac and Renal Fibrotic Pathways in Experimentally-Induced Animal Model
ArticleTelmisartan inhibits the non-canonical TGF-β/JAK2/STAT3 signaling pathway and prevents carbon tetrachloride-induced liver fibrosis in rats
ArticleTelmisartan inhibits the non-canonical TGF-β/JAK2/STAT3 signaling pathway and prevents carbon tetrachloride-induced liver fibrosis in rats
ArticleStudy of the Antifibrotic Effect of Olmesartan on the Carbon Tetrachloride- Induced liver Toxicity in Rats
ArticleStudy of the Antifibrotic Effect of Olmesartan on the Carbon Tetrachloride- Induced liver Toxicity in Rats
ThesisAntifibrotic potential of a selective Cox-2 inhibitor (celecoxib) and a synthetic PPAR gamma ligand (pioglitazone) on liver fibrosis in rats
ThesisAntifibrotic potential of a selective Cox-2 inhibitor (celecoxib) and a synthetic PPAR gamma ligand (pioglitazone) on liver fibrosis in rats
ArticleCombination Therapy with Vitamin D and Telmisartan to Suppress the Progression of Liver Fibrosis.
ArticleCombination Therapy with Vitamin D and Telmisartan to Suppress the Progression of Liver Fibrosis.
ArticleAdaptation of TIMP-1/P21 Signaling Pathways in Hepatic Fibrosis Induced in Albino Rats Using Telmisartan with Vitamin D
ArticleAdaptation of TIMP-1/P21 Signaling Pathways in Hepatic Fibrosis Induced in Albino Rats Using Telmisartan with Vitamin D
ArticleAliskiren and Fenofibrate Constrict Liver Fibrosis by means of Focusing on TGF-β1/Smad Signaling Pathway and Actuating HGF Expression
ArticleAliskiren and Fenofibrate Constrict Liver Fibrosis by means of Focusing on TGF-β1/Smad Signaling Pathway and Actuating HGF Expression